HaemMetabolome will provide research training in the study of molecular mechanisms underlying the pathogenesis of several acute haematological malignancies (Acute Myeloid Leukaemia (AML), Chronic Myeloid Leukaemia (CML) and Multiple Myeloma). Resistance to existing therapies is frequently observed for these diseases, and they remain incurable for the majority of cases.